Accu-Break, Alembic in new Accu-Break tablets development agreement
09:27 EDT 8 Aug 2012 | Pharmaceutical Business Review
Alembic Pharmaceuticals has entered into a license agreement with Accu-Break Pharmaceuticals (ABP) to develop new brand products that will use ABP's Accu-Break tablet technologies.
Original Article: Accu-Break, Alembic in new Accu-Break tablets development agreement
More From BioPortfolio on "Accu-Break, Alembic in new Accu-Break tablets development agreement"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
